Gladstone in the News
The Gladstone Institutes is gratified to receive media attention from around the globe. Check out the highlights of recent press coverage of Gladstone scientists and research. For other news, please be sure to follow us on Facebook and Twitter.
Cardiovascaular medicine at Stanford University and the Gladstone Institutes looks to stem cells for answers.
Gladstone Director of Virology and Immunology, Warner C. Greene, MD, PhD, weighs in on Gilead's efforts to develop a functional cure for HIV.
Gladstone HIV expert Warner C. Greene, MD, PhD, weighs in on new research pointing to gene therapy as a way to combat HIV
Researchers at the Gladstone Institutes in California have turned skin cells in mice into insulin producing beta cells, effectively curing the animals of diabetes.
Gladstone HIV-prevention expert Robert Grant, MD, MPH, weighs in on the latest tool that could prevent the spread of the virus: a periodic injection.
In a medical first, scientists at the Gladstone Institutes and the University of California, San Francisco (UCSF) have transformed human skin cells into mature, fully functioning liver cells.
For some years now researchers have been able to take stem cells and turn them into heart muscle cells that actually beat in time with each other. Now CIRM-funded researchers at the Gladstone Institutes have come up with a way to create those same kinds of cells in a more efficient and, importantly, more complete way.
Gladstone stem cell scientist Sheng Ding, PhD, weighs in on the controversy surrounding the STAP method of generating stem cells.
Scientists at Gladstone Institutes in San Francisco have provided hope for a treatment for type 1 diabetes by developing a technique to reprogram skin cells into insulin-producing beta cells.
Scientists believe they may have moved a step closer to a cure for the type of diabetes that develops in childhood and usually leads to a lifetime of insulin injections.